Heading in the wrong direction - Avis employé Anonymous- Salaried Staff BeOne

2,0
12 juin 2024
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Your peers and team members have some good people that are smart and dedicated. If left alone or given the right guidance, they would excel and drive the company towards eventual success. Pipeline is decent although inability to prioritize assets for development burning a lot of cash.

Inconvénients

Senior management is the worse I have seen (and I have seen some bad ones). People that joined when company was a couple of 100 people and have no clue how to run a 10,000 person company. No one dares question status quo and CEO thinks they have a unique strategy that will set them apart from everyone. We try to act like a global company but unwilling to loosen the China legacy shackles. COO is China based and really only knows that market.

Découvrez plus d’avis sur BeOne

5,0
24 avr. 2026
Employé (anonyme)
Recommande
Approbation du PDG
Perspective commerciale

Avantages

BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.

Inconvénients

Fast timelines and global expansion may translate into heavy workload and urgency

3,0
5 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Good wprk tee lunch and free commute

Inconvénients

Bad work but bad commute to work

Voir les avis par: Utile|Évaluation|Date|Tout